Press releases
Tags
Efficacy of Esophageal Cancer Postoperative Adjuvant Treatment, Peptide Vaccine Treatment, Elucidated 5-year Survival Rate Approx. Doubled for Esophageal Cancer Patients - Kindai University
Press releases • Sep 01, 2020 00:50 UTC
Kindai University’s Faculty of Medicine has, in a world first, shown the efficacy of cancer-specific vaccine therapy as a postoperative adjuvant therapy in a phase 2 clinical trial. Administration of cancer-specific vaccine therapy roughly doubled the 5-year survival rate of advanced esophageal cancer patients. Vaccine therapy amplifying CTL2 is expected to help validate peptide vaccine therapy.
Discovery of Novel Nuclear Structure Inside Fertilized Eggs - Research Results Bring Us Closer to Solving the Riddle of the Development of Animals -- Kindai University
Press releases • Jul 07, 2020 05:11 UTC
This research is expected to contribute to the development of reproductive medicine, including human infertility treatment, and animal breeding technology through practical application of the special characteristics of fertilized eggs that were discovered.
Slack for higher education: Kindai to Become First Japanese University to Invigorate University-wide Communications and Smoothen the Delivery of Online Classes - Kindai University
Press releases • Jun 30, 2020 01:11 UTC
- Introduction of Slack aims to build a new communication platform for staff and students institution wide - Utilization of Slack enhances the effectiveness of distance learning solutions - Expansion of student support through user-friendly Slack
Efficacy of Opdivo (Nivolumab) in Cancer of Unknown Primary Cases Confirmed - Kindai University
Press releases • Jun 11, 2020 08:53 UTC
- Efficacy of molecular target drug Nivolumab verified in investigator-initiated clinical trial for use with CUP by hospital team from Kindai University’s Faculty of Medicine - Reductions by more than half in tumor size in over 20% of CUP patients observed - Nivolumab expected to become standard treatment for CUP cases with no standard treatment
ALMA Resolves Gas Impacted by Young Jets from Supermassive Black Hole - Kindai University
Press releases • Mar 27, 2020 10:00 UTC
Astronomers obtained the first resolved image of disturbed gaseous clouds in a galaxy 11 billion light years away by using ALMA. The team found that the disruption is caused by young powerful jets ejected from a supermassive black hole residing at the center of the host galaxy. This result will cast light on the mystery of the evolutionary process of galaxies in the early Universe.
Preclinical Stage Verification for Combined Use of a Drug Under Development with an Existing Drug to Stimulate the Immune System to Attack Cancer Cells - Kindai University
Press releases • Nov 01, 2019 05:00 UTC
The research team from Kindai University's Faculty of Medicine, in cooperation with DAIICHI SANKYO COMPANY, LIMITED, have verified at the preclinical stage that using the currently under-development anti-cancer drug, U3-1402*1, in combination with immune checkpoint inhibitors*2 has the potential to be an effective treatment.
Kindai University Students Work on Market Development of “Gokiburi Hoi Hoi” (Cockroach Catcher) in Vietnam.
Press releases • Sep 05, 2019 04:00 UTC
Kindai University and Teikyo University have cooperated on an overseas internship program in Ho Chi Minh City in Vietnam. Students worked on developing new markets for "Gokiburi Hoi Hoi" (Earth Cooperation) through a problem solving project-based learning program. After returning to Japan, the students will give a presentation of their marketing strategies to the CEO of Earth Cooperation.
Ground Breaking Development of World’s First CurativeTreatment of Intractable Hepatocellular Carcinoma Path to Establishment of Standard Treatment of Hepatocellular Carcinoma - Kindai University
Press releases • Aug 05, 2019 02:00 UTC
Senior Administrator Masatoshi Kudo of Kindai University Faculty of Medicine, Department of Gastroenterology and Hepatology, with his research group has invented a new method (LEN-TACE) of treating patients with intractable multinodular or large liver cancers, particularly those with near advanced liver cancer.
Mechanism Behind Onset of Autoimmune Pancreatitis Caused by Changes in Intestinal Flora Elucidated Development of New Treatment Methods Expected - Kindai University
Press releases • Jul 10, 2019 01:00 UTC
Kindai University have discovered, for the first time in the world, a deep link between changes in the maintained balance of accumulated co-existing intestinal flora (bacteria) and immune responses in patients with chronic disease of the pancreas caused by autoimmune pancreatitis. This paper will be published online at midnight Japan time, July 10th, 2019, in “International Immunology”.
Successful Construction of Artificial Cell Nuclei Inside of Fertilized Egg; A World First One Part of the Cell Nuclei Structure Formation Mechanism Elucidated - Kindai University
Press releases • Jun 13, 2019 05:50 UTC
A Research group comprised of Kindai University’s Faculty of Biology-oriented Science and Technology , the National Institute of Information and Communications Technology and Osaka University have focused their attention on the building blocks of life, DNA, and in a world first, the group has artificially created cell nuclei structures in living mouse fertilized eggs.
Cell nuclei of 28,000-years-old mammoth reacted in living embryos by cloning technology
Press releases • Mar 12, 2019 02:03 UTC
-We have succeeded in observing the reconstruction of cell nuclei collected from mammoth fossils inside living mouse oocytes. -Mammoth’s cell nuclei were found to have retained biological activity for 28,000 years in permafrost. -This study paves a way for decoding old biological information using cell nuclei of ancient creatures and future leaps of evolutionary biology are expected.
Immuno-pathogenesis of Chronic Pancreatic Diseases Uncovered Applications expected for the treatment of pancreatic diseases and preventive measures for pancreatic cancer - Kindai University
Press releases • Oct 25, 2018 16:00 UTC
Until now, the barely understood immuno-pathogenesis for chronic inflammation of the pancreas has been uncovered. The pathogenic immune response that is common for both autoimmune pancreatitis and chronic pancreatitis was elucidated for the first time in the world. Applications are expected for new treatments of chronic pancreatic inflammation and new preventive measures for pancreatic cancer.
Permeation Mechanism of Water through Polymeric Membrane; Clarified for the First Time in the World Expectations for Development of Membranes with Functions, Such As Seawater Desalination - Kindai University
Press releases • Oct 14, 2018 23:00 UTC
Associate Professor Noriyoshi Arai and his research group at the Mechanical Engineering Department at the Faculty of Science and Engineering of Kindai University have elucidated the mechanism of permeation through polymeric membranes. The findings of this research will be featured in the Journal of Membrane Science , on October 15, 2018 at 8:00 AM (JST).
Successful Use of AI Technology for Efficient Prediction of Physical Properties of Substances with Complex Molecular Structures
Press releases • Sep 14, 2018 23:00 UTC
- The study demonstrated that machine learning can be applied to predict physical properties of functional materials that have complex structures. - For the first time in the world, machine learning methodology has been applied to the analysis of complex molecular structures of surfactants that are used in our immediate surroundings, such as detergents and cosmetic products.
Luminol reaction for fecal occult blood -New application of a forensic blood detection method-
Press releases • Aug 24, 2018 14:00 UTC
1.Experiments have shown that the luminol reaction can be used to detect FOB in animals. 2.This is the first standard method to detect FOB in animal models for ulcers and cancers in the digestive system - which is simple, quick, economical and quantitative - making it applicable to use for any research laboratories.
World’s First Demonstration on Efficacy of Drug for Lung Cancer Genetic Mutation Diagnosed with Blood sample using cobas EGFR mutation test v2.Alleviating burden on patients through diagnosis with blood tests
Press releases • Jul 31, 2018 07:09 UTC
[Key aspects of this study] - World’s first research findings that demonstrate efficacy and safety of a drug which is administered based on genetic screening results. - Efficacy demonstrated by a response rate of 55.1%, which represents the ratio of people whose tumor shrunk. - Potential for partial transition to blood test from endoscopic biopsy, which places a heavy burden on patients.